Fernanda Borges Selected Research

Chromones

2/2019	Searching for new cytotoxic agents based on chromen-4-one and chromane-2,4-dione scaffolds.
10/2018	Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
11/2017	Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold.
10/2017	Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernanda Borges Research Topics

Disease

19	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2011
16	Neoplasms (Cancer) 03/2022 - 12/2003
15	Parkinson Disease (Parkinson's Disease) 09/2022 - 01/2013
11	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2013
9	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 05/2006
4	Infections 05/2022 - 09/2013
4	Cardiotoxicity 11/2008 - 01/2003
3	Nervous System Diseases (Neurological Disorders) 04/2022 - 01/2016
3	Disease Progression 01/2020 - 05/2014
2	Neuroblastoma 02/2021 - 03/2019
2	Drug-Related Side Effects and Adverse Reactions 01/2020 - 03/2008
2	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2019 - 12/2013
2	Adenocarcinoma 03/2019 - 12/2003
2	Communicable Diseases (Infectious Diseases) 10/2017 - 07/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2017 - 12/2003
2	Breast Neoplasms (Breast Cancer) 05/2011 - 05/2011
2	Necrosis 09/2010 - 10/2006
2	Hemolysis 01/2010 - 05/2009
1	Ulcer 05/2022
1	Wound Infection (Wound Infections) 05/2022
1	Wounds and Injuries (Trauma) 05/2022
1	Diabetic Foot 05/2022
1	Endometrial Neoplasms (Endometrial Cancer) 03/2022
1	Small Cell Carcinoma 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Osteoporosis 08/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Gout 11/2020
1	Hyperuricemia 11/2020
1	Mental Disorders (Mental Disorder) 09/2020
1	Schizophrenia (Dementia Praecox) 09/2020
1	Epilepsy (Aura) 09/2020
1	Hypersensitivity (Allergy) 02/2020
1	Ganglion Cysts (Ganglion) 12/2019
1	Nephrolithiasis 02/2019

Drug/Important Bio-Agent (IBA)

14	AntioxidantsIBA 03/2022 - 04/2013
13	Pharmaceutical PreparationsIBA 01/2022 - 03/2008
10	Monoamine Oxidase (MAO)IBA 02/2021 - 01/2011
7	LigandsIBA 11/2019 - 10/2015
6	Biological ProductsIBA 09/2022 - 01/2018
6	caffeic acidIBA 03/2022 - 12/2016
4	SolutionsIBA 03/2022 - 01/2014
4	ChromonesIBA 02/2019 - 10/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 07/2016
3	CalciumIBA 08/2021 - 09/2010
3	CoumarinsIBA 01/2021 - 03/2014
3	EstersIBA 12/2018 - 12/2016
2	PhytochemicalsIBA 05/2022 - 07/2016
2	CationsIBA 03/2022 - 01/2018
2	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022 - 11/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 02/2021 - 01/2011
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 10/2020 - 07/2019
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2020 - 01/2012
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 01/2018
2	AmidesIBA 12/2019 - 01/2017
2	Tolcapone (Tasmar)FDA Link 03/2019 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 02/2019 - 08/2017
2	PolyphenolsIBA 01/2019 - 05/2009
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2018 - 05/2014
2	EnzymesIBA 11/2017 - 05/2014
2	Caffeic AcidsIBA 08/2017 - 12/2003
2	Neuroprotective AgentsIBA 01/2017 - 12/2015
2	Purinergic P1 Receptor AntagonistsIBA 01/2016 - 12/2013
2	BenzopyransIBA 01/2015 - 12/2014
2	Estrogens (Estrogen)FDA Link 05/2011 - 05/2011
2	3,4-dihydroxyphenylethanol-elenolic acid dialdehydeIBA 01/2010 - 05/2009
2	Olive OilIBA 01/2010 - 05/2009
2	ProteomeIBA 11/2008 - 03/2008
2	Cocaine (Cocaine HCl)IBA 08/2007 - 05/2006
2	Heroin (Diamorphine)IBA 08/2007 - 04/2007
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2006 - 05/2004
1	Oxacillin (Prostaphlin)FDA LinkGeneric 05/2022
1	Methicillin (Metin)FDA Link 05/2022
1	Mupirocin (Bactroban)FDA LinkGeneric 05/2022
1	Gentamicins (Gentamicin)FDA LinkGeneric 05/2022
1	Fusidic Acid (Fucithalmic)IBA 05/2022
1	Oxidoreductases (Dehydrogenase)IBA 04/2022
1	triphenylphosphoniumIBA 03/2022
1	glycolic acid (glycolate)IBA 01/2022
1	MineralsIBA 08/2021
1	StrontiumIBA 08/2021
1	Diphosphonates (Bisphosphonates)IBA 08/2021
1	MagnesiumIBA 08/2021
1	CatecholsIBA 02/2021
1	IronIBA 01/2021
1	Uric Acid (Urate)IBA 11/2020
1	Dopamine (Intropin)FDA LinkGeneric 10/2020
1	pyridineIBA 03/2020
1	Dihydrotachysterol (AT 10)IBA 03/2020
1	Disinfectants (Biocides)IBA 02/2020
1	piperineIBA 01/2020
1	Retinaldehyde (Retinal)IBA 12/2019
1	ButyrylcholinesteraseIBA 07/2019
1	AcetylcholinesteraseIBA 07/2019
1	Levodopa (L Dopa)FDA LinkGeneric 07/2019
1	OxalatesIBA 02/2019
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2018
1	nitroxylIBA 01/2018

Therapy/Procedure

19	Therapeutics 09/2022 - 08/2007